Carcinoma, Non-Small-Cell Lung: all 6,641 studies

Page 62 of 67. Open to participants first (1,665), then studies with results posted, then the rest; newest registration first within each.

• Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) PatientsCompletedNCT00457119Phase 1
• Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With ChemotherapyCompletedNCT00456833Phase 1
• Cancer Immunotherapy GSK1572932A as Adjuvant Therapy for Patients With Tumor-antigen-positive Non-Small Cell Lung CancerTerminatedNCT00455572Phase 1
• A Study of Intravenous XMT-1001 in Patients With Advanced Solid TumorsCompletedNCT00455052Phase 1
• Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00453115Phase 2
• Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)Status unknownNCT00452803Phase 2
• Erlotinib as First-line Treatment of Advanced Non-small Cell Lung Cancer (NSCLC) for Patients Unfit for ChemotherapyTerminatedNCT00452075Phase 2
• S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung CancerCompletedNCT00450281
• Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLCTerminatedNCT00449657Phase 2
• Carboplatin, Irinotecan, and Radiation Therapy Followed By Docetaxel in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung CancerCompletedNCT00449020Phase 2
• Fluorine F 18 FEQA in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer and in Healthy ParticipantsTerminatedNCT00444223Not applicable
• Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)CompletedNCT00444015Phase 1
• Dendritic Cells in Lung CancerCompletedNCT00442754Phase 2
• Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLCTerminatedNCT00442026Phase 3
• Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC)CompletedNCT00441922Phase 3
• Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung CancerCompletedNCT00441740Phase 3
• Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00440414Phase 3
• A Study of CBT-1 and Paclitaxel With Carboplatin in Patients With Advanced Inoperable Non-small Cell Lung CancerTerminatedNCT00437749Phase 3
• Evaluation of Tolerability of Adjuvant Cisplatin/Docetaxel in Completely Resected Stage IB/II Non-Small Cell Lung CancerCompletedNCT00434668Phase 2
• Safety of Everolimus and Pemetrexed in Lung Cancer PatientsCompletedNCT00434174Phase 1
• Alimta and Gemcitabine in Non-Small Cell Lung CancerCompletedNCT00434135Phase 2
• Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study)CompletedNCT00432640Not applicable
• Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC)TerminatedNCT00431613Phase 2
• Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)CompletedNCT00430651Phase 3
• Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00425646Phase 2
• Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.CompletedNCT00425191Phase 2
• VATS Lobectomy for Clinical Stage IB or II Lung CancerStatus unknownNCT00425022Phase 2
• ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00424853Phase 2
• Vaccine Maintenance Treatment for Non-Small Cell Lung CancerTerminatedNCT00420732Phase 2
• Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00419042
• Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)CompletedNCT00418704
• Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT00415818Phase 2/3
• Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00411047Phase 2
• Radiation Therapy in Treating Patients With Non Small Cell Lung Cancer That Has Been Completely Removed by SurgeryStatus unknownNCT00410683Phase 3
• BATTLE Program: Umbrella Protocol for Patients With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00409968
• Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung CancerCompletedNCT00408226Phase 1/2
• Immune Response on Neoadjuvant Therapy in Non-small-cell Lung Cancer (NSCLC)CompletedNCT00406302Phase 2
• A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung CancerTerminatedNCT00404703Phase 2
• Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By SurgeryCompletedNCT00403065Phase 3
• MILES-02: Study of Chemotherapy Treatment and Toxicity in Elderly Patients With Advanced Non Small Cell Lung CancerCompletedNCT00401492Phase 2
• A Phase 1/2 Trial of Perifosine in the Treatment of Non-Small Cell Lung CancerCompletedNCT00399789Phase 1/2
• Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung CancerStatus unknownNCT00398385Phase 2
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL)CompletedNCT00391248Phase 2
• Pemetrexed Disodium and Cisplatin Before or After Surgery in Treating Patients With Stage IB or Stage II Non-Small Cell Lung Cancer That Can be Removed by SurgeryTerminatedNCT00389688Phase 2
• A Study of Avastin in Combination With Chemotherapy for Treatment of Colorectal Cancer and Non-Small Cell Lung Cancer (ARIES)CompletedNCT00388206
• Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by BevacizumabCompletedNCT00387374Phase 2
• Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid TumorsCompletedNCT00387322Phase 1/2
• A Phase 2 Study in Patients With Advanced Non-Small Cell Lung Cancer Using New Agents With and Without Docetaxel.WithdrawnNCT00386555Phase 2
• Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLCCompletedNCT00385606Phase 2/3
• The Utility of PET/CT in the Planning of Stereotactic Body Radiotherapy for Non-small Cell Lung CancerWithdrawnNCT00380666Not applicable
• Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT00379717Phase 1/2
• Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to BrachytherapyCompletedNCT00379665Phase 2
• Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLCTerminatedNCT00378404Phase 1
• Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)TerminatedNCT00373204Phase 2
• AZD6244 Versus Pemetrexed (Alimta®) in Patients With Non-small Cell Lung Cancer, Who Have Failed One or Two Prior Chemotherapy RegimenCompletedNCT00372788Phase 2
• High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR MutationsCompletedNCT00372515Phase 1
• Endobronchial Ultrasound vs Mediastinoscopy in NSCLCCompletedNCT00372203Phase 2
• Efficacy Study of Oral Seliciclib to Treat Non-Small Cell Lung CancerTerminatedNCT00372073Phase 2
• A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)CompletedNCT00370383Phase 2
• Bevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Advanced Non-Small Cell Lung CancerTerminatedNCT00369551Phase 1
• A Study of Nimotuzumab in Combination With External Radiotherapy in Non-Small Cell Lung CancerTerminatedNCT00369447Phase 1/2
• A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLCTerminatedNCT00369070Phase 2
• Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung CancerTerminatedNCT00365183Phase 2
• Study of XL647 in Subjects With Non-Small-Cell Lung CancerCompletedNCT00364780Phase 2
• The Utility and Cost-Effectiveness Analysis of 18F-FDG PETin Staging Potential Operable Non-Small Cell Lung CancerStatus unknownNCT00364663
• Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)TerminatedNCT00359450Phase 2
• A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung CancerTerminatedNCT00354562Phase 1/2
• Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung CancerWithdrawnNCT00352950Phase 1
• Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT00352391
• Lung Tumour Volume DatabaseCompletedNCT00351598
• TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung CancerCompletedNCT00349219Phase 3
• Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung CancerCompletedNCT00349102Phase 3
• Trial on Refinement of Early Stage Lung Cancer Adjuvant TherapyCompletedNCT00349089Phase 2
• Study of NOV-002 in Combination With Chemotherapy to Treat Lung CancerCompletedNCT00347412Phase 3
• CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC)CompletedNCT00346801Phase 1
• Radiation in Stage I or Stage II Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryCompletedNCT00346320Not applicable
• The DISTAL-2 Study: Docetaxel Alone or in Combination in Second-line Treatment of Advanced Non Small-Cell Lung CancerTerminatedNCT00345059Phase 3
• Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior TherapyCompletedNCT00343720Phase 2
• AZD2171 and Standard Combination Chemotherapy in Advanced Non-Small Cell Lung Cancer or Colorectal CancerCompletedNCT00343408Phase 1
• A Phase II Study of ACZONE™ (Dapsone) Gel, 5% As a Treatment For Tarceva® (Erlotinib)Related RashTerminatedNCT00343187Phase 2
• Prevention of Tumor Spread Due to Lung Cancer SurgeryCompletedNCT00341380
• First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR GeneStatus unknownNCT00339586Phase 2
• Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung CancerTerminatedNCT00334763Phase 2
• Phase II Iressa + Irradiation Followed by Chemo in NSCLCCompletedNCT00333294Phase 2
• CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung CancerCompletedNCT00330746Phase 2
• Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung CancerCompletedNCT00330044Phase 1
• Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung CancerWithdrawnNCT00329472Phase 3
• LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With ChemotherapyCompletedNCT00328588Phase 2
• A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.CompletedNCT00327535Phase 2
• Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer PatientsCompletedNCT00327288Phase 1
• Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung CancerCompletedNCT00326378Phase 3
• A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerCompletedNCT00325494Phase 1
• Trial Of Erlotinib With Or Without PF-3512676 In Advanced Non Small Cell Lung CancerCompletedNCT00321815Phase 2
• Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLCCompletedNCT00321334Phase 3
• Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung CancerTerminatedNCT00321308Phase 2
• Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCStatus unknownNCT00319800Phase 2
• Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLCCompletedNCT00319514Phase 2
• Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung CancerCompletedNCT00315185Phase 2
• Randomized Ph 2 Trial Of Paclitaxel/Carboplatin /Bevacizumab + PF-3512676 And P/C/B Alone In Advanced Nonsquamous NSCLCTerminatedNCT00313768Phase 2

← Carcinoma, Non-Small-Cell Lung overview